Role of 3.0 T multiparametric MRI in local staging in prostate cancer and clinical implications for radiation oncology

Clinical and Translational Oncology

Volumn 16, Issue 11, 2014, Pages 993-999

  Counago F ^a   Recio, M ^b   del Cerro, E ^a   Cerezo, L ^c   Diaz Gavela A ^a   Marcos, F J ^a   Murillo, R ^b   Rodriguez Luna, J M ^b   Thuissard, I J ^d   Martin, J L R ^d  

^a Hospital Universitario Quiron Madrid   (Spain)

^b Hospital Universitario Quiron   (Spain)

^c HOSPITAL UNIVERSITARIO DE LA PRINCESA   (Spain)

^d UNIVERSIDAD EUROPEA DE MADRID   (Spain)

Author keywords

3T MRI; Hormone therapy; Multiparametric MRI; Prostate cancer; Radiation therapy; Staging

Indexed keywords

ADULT; AGED; ARTICLE; CANCER HORMONE THERAPY; CANCER RADIOTHERAPY; CANCER STAGING; DIAGNOSTIC TEST ACCURACY STUDY; GLEASON SCORE; HIGH RISK PATIENT; HUMAN; INTERMEDIATE RISK PATIENT; LOW RISK PATIENT; MAJOR CLINICAL STUDY; MALE; MULTIPARAMETRIC NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; PROSTATE ADENOCARCINOMA; PROSTATE BIOPSY; PROSTATE CANCER; PROSTATECTOMY; TRANSRECTAL ULTRASONOGRAPHY; ADENOCARCINOMA; COMPUTER ASSISTED RADIOTHERAPY; MIDDLE AGED; ONCOLOGY; PATHOLOGY; PROCEDURES; PROSTATE TUMOR; RETROSPECTIVE STUDY;

ADENOCARCINOMA; AGED; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NEOPLASM STAGING; PROSTATIC NEOPLASMS; RADIATION ONCOLOGY; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RETROSPECTIVE STUDIES;

EID: 84919836287     PISSN: 1699048X     EISSN: 16993055     Source Type: Journal    
DOI: 10.1007/s12094-014-1186-6     Document Type: Article

References (28)

1. Siegel R1, Ma J, Zou Z, Jemal A (2014) Cancer statistics. CA Cancer J Clin 64:9–29.
2. Edge S, Byrd DR, Compton CC, Fritz AG, Greene FL, Trotti A. American Join Committee on Cancer Staging Manual. 7th ed. New York: Springer; 2010.
3. Freedland SJ. Screening, risk assessment, and the approach to therapy in patients with prostate cancer. Cancer. 2011;117:1123–35.
4. Bostwick DG. Staging prostate cancer 1997: current methods and limitations. Eur Urol. 1997;32:2–14.
5. Spiegelman SS, McNeal JE, Freiha FS, Stamey TA. Rectal examination in volume determination of carcinoma of the prostate: clinical and anatomical correlations. J Urol. 1986;136:1228–30.
6. Smith JA Jr, Scardino PT, Resnick MI, Hernandez AD, Rose SC, Egger MJ. Transrectal ultrasound versus digital rectal examination for the staging of carcinoma of the prostate: results of a prospective multi-institutional trial. J Urol. 1997;157:902–6.
7. Boonsirikamchai P, Choi S, Frank SJ, Ma J, Elsayes KM, Kaur H, et al. MR imaging of prostate cancer in radiation oncology: what radiologists need to know. Radiographics. 2013;33:741–76.
8. Mullerad M, Hricak H, Kuroiwa K, Pucar D, Chen HN, Kattan MW, et al. Comparison of endorectal magnetic resonance imaging, guided prostate biopsy and digital rectal examination in the preoperative anatomical localization of prostate cancer. J Urol. 2005;174:2158–63.
9. Sala E, Akin O, Moskowitz CS, Eisenberg HF, Kuroiwa K, Ishill NM, et al. Endorectal MR imaging in the evaluation of seminal vesicle invasion: diagnostic accuracy and multivariate feature analysis. Radiology. 2006;238:929–37.
10. Wang L, Mullerad M, Chen HN, Eberhardt SC, Kattan MW, Scardino PT, et al. Prostate cancer: incremental value of endorectal MRI findings for prediction of extracapsular extension. Radiology. 2004;232:133–9.
11. Mullins JK1, Bonekamp D, Landis P, Begum H, Partin AW, Epstein JI et al (2013) Multiparametric magnetic resonance imaging findings in men with low-risk prostate cancer followed using active surveillance. BJU Int 111:1037–1045.
12. Dickinson L, Ahmed HU, Allen C, Barentsz JO, Carey B, Futterer JJ, et al. Magnetic resonance imaging for the detection, localisation, and characterisation of prostate cancer: recommendations from a European Consensus Meeting. Eur Urol. 2011;59:477–94.
13. Barentsz OJ, Richenberg J, Clements R, Choyke P, Verma S, Villeirs G, et al. Esur prostate MR guidelines 2012. Eur Radiol. 2012;22:746–57.
14. Fütterer JJ, Heijmink SW, Scheenen TW, Jager GJ, Hulsbergen-Van de Kaa CA, Witjes JA, et al. Prostate cancer: local staging at 3-T endorectal MR imaging-early experience. Radiology. 2006;238:184–91.
15. Augustin H, Fritz GA, Ehammer T, Auprich M, Pummer K. Accuracy of 3-Tesla magnetic resonance imaging for the staging of prostate cancer in comparison to the Partin tables. Acta Radiol. 2009;50:562–9.
16. Heijmink SW, Fütterer JJ, Hambrock T, Takahashi S, Scheenen TW, Huisman HJ, et al. Prostate cancer: body-array versus endorectal coil MR imaging at 3T-comparison of image quality, localization, and staging performance. Radiology. 2007;244:184–95.
17. Torricelli P, Barberini A, Cinquantini F, Sighinolfi M, Casinaro AM. 3-T MRI with phased-array coil in local staging of prostatic cancer. Acad Radiol. 2008;15:1118–25.
18. Beyersdorff D, Taymoorian K, Knösel T, Schnorr D, Felix R, Hamm B, et al. MRI of prostate cancer at 1.5 and 3.0: comparison of image quality in tumor detection and staging. AJR. 2005;185:1214–20.
19. Park BK, Kim B, Kim CK, Lee HM, Kwon GY. Comparison of phased-array 3.0-T and endorectal 1.5-T magnetic resonance imaging in the evaluation of local staging accuracy for prostate cancer. J Comput Assist Tomogr. 2007;31:534–8.
20. Sciarra A, Barentsz J, Bjartell A, Eastham J, Hricak H, Panebianco V, et al. Advances in magnetic resonance imaging: how they are changing the management of prostate cancer. Eur Urol. 2011;59:962–77.
21. Mohler JL, Kantoff PW, Armstrong AJ, Bahnson RR, Cohen M, D’Amico AV, et al. Prostate cancer, version 1.2014. J Natl Compr Cancer Netw. 2013;11:1471–9.
22. Heidenreich A, Bastian PJ, Bellmunt J, Bolla M, Joniau S, van der Kwast T, et al. EAU Guidelines on prostate cancer. Part 1: screening, diagnosis, and local treatment with curative intent-update 2013. Eur Urol. 2014;65:124–37.
23. Boehmer D, Maingon P, Poortmans P, Baron MH, Miralbell R, Remouchamps V, et al. Guidelines for primary radiotherapy of patients with prostate cancer. Radiother Oncol. 2006;79:259–69.
24. Chao KK, Goldstein NS, Yan D, Vargas CE, Ghilezan MI, Korman HJ, et al. Clinicopathologic analysis of extracapsular extension in prostate cancer: should the clinical target volume be expanded posterolaterally to account for microscopic extension? Int J Radiat Oncol Biol Phys. 2006;65:999–1007.
25. Tamada T, Sone T, Jo Y, Yamamoto A, Yamashita T, Egashira N, et al. Prostate cancer: relationships between post biopsy hemorrhage and tumor detectability at MR diagnosis. Radiology. 2008;248:531–9.
26. Walsh PC. Anatomic radical prostatectomy: evolution of the surgical technique. J Urol. 1998;160:2418–24.
27. Hedge JV, Chen MH, Mulken RV, Fennessy FM, D’Amico AV, Tempany CM. Preoperative 3-Tesla multiparametric endorectal magnetic resonance imaging findings and the odds of upgrading and upstaging at radical prostatectomy in men with clinically localized prostate cancer. Int J Radiat Oncol Biol Phys. 2013;85:101–7.
28. Cerantola Y, Valerio M, Kawkabani Marchini A, Meuwly JY, Jichlinski P. Can 3T multiparametric magnetic resonance imaging accurately detect prostate cancer extracapsular extension? Can Urol Assoc J. 2013;7:699–703.